The first VIP3000 Expert Dialogue held on 11 and 12 April 2019 drew more than 80 interested participants to Hamburg with the topic “The Perfect Pharmaceutical Project”. Ralf Gengenbach, CEO of gempex GmbH and President of the VIP30000 (Verein...
Customers of the Swiss contract research institute IBR Inc. can look forward to complete support from pre-clinical research to product approval going forward. GMP certification by Swissmedic was issued in February of 2019 following a GMP upgrade.
Going forward, b+b Automations- und Steuerungstechnik GmbH is able to supply its customers with the appropriate IT validation documents for their software solutions. End customers are therefore able to independently and reliably perform a GxP-compliant...
The expert dialogue “The perfect pharmaceuticals project”, a VIP3000 event, is taking place in Hamburg, Germany on 11/12 April 2019. As a member of the VIP3000, the GMP service provider gempex is helping to organise the event.
The GMP service provider gempex invites you to intense discussions of the GMP working environment. At the jobvector career day on 19 February 2019 in Munich, at the T5 JobMesse on 27 March 2019 in Stuttgart and on 2 April 2019 at the University of Mannheim.
Joint presentation with Rühl, a manufacturer of disinfectants for healthcare applications, at LOUNGES in Karlsruhe. Wednesday, 6 February 2019 at 1:30 pm in room 3.
For gempex, 2019 will continue to be defined to a large extent by current issues in the areas of IT validation and modern qualification. It starts with the clean room and pharmaceuticals sector when the LOUNGES trade fair opens its doors in Karlsruhe on...
gempex has been awarding German scholarships to biotechnology students at the University of Mannheim every year since 2010. This year the presentation took place on 28 November 2018 with a ceremonial supporting programme at the university as part of University...
The amendment of the Swiss Therapeutic Products Act (HMG) comes into force in 2019. Optimising safety, improving transparency and facilitating market access are only some of the key points of interest, especially for pharmacy operations that produce...
This Internet presence uses cookies. I consent to the use of cookies. For further information and the possibility to raise an objection, please click on ourPrivacy Policy.
